Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic? | Neurotherapeutics;21(4): e00386, 2024 Jun 26. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?

Bourdette, Dennis; Wooliscroft, Lindsey.

Affiliation

Bourdette D; Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: bourdett@ohsu.edu.
Wooliscroft L; Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA; Neurology Service, Portland VA Health Care System, Portland, OR 97239, USA.

Neurotherapeutics ; 21(4): e00386, 2024 Jun 26.

Article in En | MEDLINE | ID: mdl-38937160

Key words

In vitro; Multiple sclerosis; OPC; Oligodendrocytes; Remyelination

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurotherapeutics Journal subject: NEUROLOGIA Year: 2024 Document type: Article Country of publication: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurotherapeutics Journal subject: NEUROLOGIA Year: 2024 Document type: Article Country of publication: Estados Unidos